✨ GUPS Distinguished Lecture Series featuring Dr. Jonathan Epstein next week!

⚖️Medicolegal Issues for Pathologists:
Important Perspectives Relating to Genitourinary Pathology

📅 Wednesday, April 8, 2026
🕛 12:00–1:30 PM EST

🔗Register here ⬇️
us02web.zoom.us/webinar/regi...

#GUpath #GUPS

✨Educational opportunity in uropathology:
The 1st Luso-Brazilian Course in Uropathology is open for registration!

🔗 Register here: zoom.us/webinar/regi...

#GUpath #MedicalEducation

Can we consider Gleason 3+3 (Grade Group 1) to be like endometrial complex atypical hyperplasia? Once there is a certain amount of confluence it becomes cancer?

Is Gleason 6 really cancer? The recently published Viewpoint of the National Cancer Institute working group on "Overdiagnosis and Overtreatment in Cancer" by Esserman and colleagues [1] raises continued discussion as to whether ...

Here are my thoughts from several years ago, but I think still hold mostly true!

www.bjuinternational.com/bjui-blog/is...

Should grade group 1 prostate cancer be renamed? Experts debate the pros and cons of a ‘noncancer’ nomenclature change January 2025—Whether grade gr...

A nice article from CAP Today - should low-grade prostate cancer be renamed?

www.captodayonline.com/should-grade...

Gender Gender offers an added layer of specificity when interpreting patterns or phenomena of human behavior. Authors are strongly encouraged to explicitly designate information about the gender identities of the participants making up their samples rather than assuming cisgender identities.

It always bothers me when authors refer to patients as males/females (as nouns) in scientific papers. We ask authors to change it for IJSP

Here is a great explanation! bit.ly/42bBWkH

Just learned about bluesky! For a first post, here is an image of ductal type prostate cancer. Diagnostic criteria can be controversial but common features are columnar cells and papillary structures. Typically considered grade 4. #GUpath